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ABSTRACT Thetwentiethcenturywasmarkedbyextraordinaryadvancesinourunderstandingofmicrobesandinfectiousdis-
ease,butpandemicsremain,foodandwaterborneillnessesarefrequent,multidrug-resistantmicrobesareontherise,andthe
neededdrugsandvaccineshavenotbeendeveloped.Thescientiﬁcapproachesofthepast—includingtheintensefocusonindi-
vidualgenesandproteinstypicalofmolecularbiology—havenotbeensufﬁcienttoaddressthesechallenges.Theﬁrstdecadeof
thetwenty-ﬁrstcenturyhasseenremarkableinnovationsintechnologyandcomputationalmethods.Thesenewtoolsprovide
nearlycomprehensiveviewsofcomplexbiologicalsystemsandcanprovideacorrespondinglydeeperunderstandingof
pathogen-hostinteractions.Totakefulladvantageoftheseinnovations,theNationalInstituteofAllergyandInfectiousDiseases
recentlyinitiatedtheSystemsBiologyProgramforInfectiousDiseaseResearch.AsparticipantsoftheSystemsBiologyProgram,
wethinkthatthetimeisathandtoredeﬁnethepathogen-hostresearchparadigm.
I
nfectious diseases continue to be major health concerns world-
wide: hepatitis C, AIDS, malaria, and tuberculosis (TB) are on-
going pandemics. A third of the world population is currently
infected with the TB bacillus; millions of people are infected by
inﬂuenza virus annually; and even though therapeutic drugs have
slowedthethreatofHIV-1,thereisstillnodeﬁnitivecureorviable
vaccine in sight. Although inﬂuenza virus vaccines provide pro-
tection, they must be reformulated annually, and the time lag
fromthespreadofapandemicvirustotheavailabilityofavaccine
is far too long. A universal vaccine against inﬂuenza virus is
needed to limit high levels of morbidity and mortality. Newly
emerginginfectiousdiseases,suchasswineH1N1inﬂuenza,avian
H5N1 inﬂuenza, severe acute respiratory syndrome (SARS), and
denguefeverareaconstantthreat;andbacterialinfections,suchas
therecurrentSalmonellaoutbreaksinthefoodindustry,arecostly
to society.
New research strategies and tactics must be employed to min-
imize these threats and improve global health. In response to this
need, the National Institute of Allergy and Infectious Diseases
(NIAID) has sponsored the Systems Biology Program for Infec-
tious Disease Research. This program consists of four centers,
each with its own unique focus on a variety of viral and bacterial
pathogens (Fig. 1). In this perspective, we discuss why the time is
rightforapplyingasystemsbiologyapproachtoinfectiousdisease
researchandhowweareimplementingthisapproachtoovercome
speciﬁc obstacles. This venture requires a new way of thinking
about how best to address the challenges of infectious disease re-
search.
DEFINING SYSTEMS BIOLOGY
Intrinsic to systems biology is the notion that biological systems
have“emergentproperties”:thatis,theirsumisgreaterthantheir
individual parts, and the biological outcomes of a system cannot
be predicted by traditional reductionist methods that study only
the individual components (1). Instead, an understanding of bio-
logicalsystemsrequirestheintegrationofhigh-throughputmulti-
omics data (transcriptomics, proteomics, metabolomics, lipido-
mics, etc.), which are used to construct predictive models of the
networks and dynamic interactions between the biological com-
ponents of the complex pathogen-host system (2). Through iter-
ativeroundsofmodeldevelopment,testing,andﬁllinginthegaps
withexperimentaldata,modelsarereﬁnedtoprovidepredictions
thatcanultimatelybeusedtohelpidentifytherapeutictargetsand
improve clinical outcomes. This iterative cycle of perturbation
biology is key to the systems biology approach (Fig. 2) and re-
quires the establishment of efﬁcient interdisciplinary collabora-
tions, the building of integrated computational infrastructures,
andthegenerationofself-consistent,comprehensive,andmodel-
speciﬁc experimental data (3).
Thetechnologies,computationalmethods,andgenomeinfor-
mationneededtosuccessfullyimplementthisapproachnowexist.
Technologies such as next-generation sequencing have opened
the door to sequencing total transcriptomes, encompassing mi-
croRNAs,longnoncodingRNAs,andmRNAs.Thishasraisedthe
possibility that a previously unappreciated class of RNAs—the
long noncoding RNAs—may play important roles in the host re-
sponse to virus infection (4). Proteomic technologies and accom-
panying informatics pipelines are evolving rapidly, with through-
put and sensitivity approaching that of microarrays.
Metabolomics, glycomics, lipidomics, and phosphoproteomics
are young and comparatively undeveloped, but the promise is
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priate in vitro and in vivo experimental systems to generate useful
pathogen-host interaction models are now available. Each of the
fourNIAIDSystemsBiologyCentershastakenauniqueapproach
to implementing this new research paradigm as outlined below.
NIAID SYSTEMS BIOLOGY CENTERS
The TB Systems Biology Center (http://www.broadinstitute.org
/annotation/tbsysbio) at Stanford is using cell culture models, to-
gether with a combination of biochemical and transcriptional
proﬁling methods, to characterize the state of the Mycobacterium
tuberculosisbacillusandthehostateachstageofitsinfectiouscycle
and during transitions between stages. Each of the three stages is
orchestratedbyadistinctgeneticprogramthatdirectstheexpres-
sion of stage-speciﬁc antigens and the activation of stage-speciﬁc
metabolic and biosynthetic pathways. There is an unusually close
interaction between the pathogen and the host immune system,
whichdependingontheoutcomeofthisinteraction,canleadtoa
stable, inactive, and asymptomatic infection that is compatible
with a normal life span (latency) or to rapid destruction of lung
tissue and death (reactivation disease). Chromatin immunopre-
cipitation followed by sequencing (ChIP-Seq) is one of the key
technologies used to identify the regulatory networks that govern
these transitions. Incorporation of these data with results from
multidimensionalassaysthatinterrogatethestatusofDNA,RNA,
proteins, lipids, and metabolites will lead to the construction of
predictivemodelsusefulinthedevelopmentofstage-speciﬁcther-
apeutics (8).
The Systems Virology Center (http://www.systemsvirology
.org) at the University of Washington is comprehensively analyz-
ing and modeling the molecular and cellular events, pathogen-
host interactions, and cellular response networks induced or
altered during the course of respiratory virus infection. This re-
search focuses on highly pathogenic H5N1 avian inﬂuenza virus
and severe acute respiratory syndrome-associated coronavirus
(SARS-CoV). For each virus, the host response to highly patho-
genic wild-type viruses and to engineered viruses with reduced
levelsofpathogenicityisbeinganalyzedandmodeled.Thesestud-
iesusecellcultureinfectionsystems,whicharethemostamenable
systemsforcomputationmodeling,aswellasmouseandmacaque
infection models. Animal models enable the incorporation of
disease-relevantcomplexityandthevalidation,extension,andre-
ﬁnement of ﬁndings obtained from cell culture systems. Design-
ingandperformingexperimentssothatcomparisonscanbemade
across the model systems are an integral but labor-intensive part
of the process. The direct communication between biologists and
modelers—constant within all of the Systems Biology Centers—
ensures that the experimental designs are suitable in terms of bi-
ological sample size, reproducibility, and consistency from high-
throughput assays to construction of predictive models and the
resulting biological interpretations. The question remains as to
whether current computational and modeling techniques are ro-
bustenoughtogeneraterelevantmodelsgiventhecomplexitiesof
these systems. However, only by attempting these types of studies
will the required methodologies be developed.
FIG1 CommonanddistinctelementsofthefourNIAIDSystemsBiologyCenters.TheNationalInstituteofAllergyandInfectiousDiseases(NIAID)sponsors
the Systems Biology Program for Infectious Disease Research. Each of the four centers focuses on unique aspects of the host-pathogen response while using
several common approaches and techniques (center circle).
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.systemsinﬂuenza.org)attheInstituteforSystemsBiologyisusing
multi-omicsapproachestocomparetheresponsesofbothinvitro
and in vivo systems to infection with inﬂuenza virus strains of
various pathogenicities. The devastating mortality of the 1918 in-
ﬂuenzapandemicwascharacterizedbybothadysregulatedinnate
immune response and a high susceptibility to secondary bacterial
pneumonias. Computational integration of the transcriptomic,
proteomic,andlipidomicdataintoanappropriatenetworkmodel
will illuminate the detailed signatures of extreme virulence and
identify the molecular mechanisms underlying these responses.
Thesestudiesarebeingextendedtoidentifyandmodelthosehost-
virus interactions that predispose an infected lung to secondary
bacterial invasion by Staphylococcus aureus. A comprehensive
model of the inﬂuenza virus-host interaction, aided signiﬁcantly
by recent advances in sequencing technologies and advances in
viralgeneticmanipulation,willservetocalibratetheglobalpublic
health response to a newly emergent strain as well as uncover
novel targets for therapeutic intervention.
The Center for Systems Biology for EnteroPathogens (http:
//www.sysbep.org/) at the Paciﬁc Northwest National Laboratory
isusingregulatoryandmetabolicmodeling,empoweredbymulti-
omics data, to characterize the interactions between the host and
distantly related bacterial pathogens Salmonella enterica serovar
Typhimurium and Yersinia species. Salmonella is a leading cause
of acute gastroenteritis worldwide, and Yersinia pestis is the caus-
ative agent of plague. As general models of infection, Salmonella
and Yersinia pestis are among the best characterized with in vitro
and in vivo animal models. These bacterial pathogens must use a
well-orchestrated series of regulatory and metabolic changes to
replicate and persist in the inhospitable host environment.
Amongthesehighlyregulatedprocessesistheprocessofsecreting
bacterial proteins into the host that modulate the host’s response
network. Early efforts have focused on developing methods to
investigate and model the coordinated regulatory and metabolic
changes occurring in the pathogen during infection and to iden-
tifyandcharacterizethesecretedbacterialproteinsresponsiblefor
manipulatingthehostnetworks(5,6).Understandingtheregula-
toryandmetabolicprogramsrequiredforinfectionwillenablethe
development of effective therapeutic treatments in the future.
WHAT ARE THE CHALLENGES AND HOW CAN SUCCESS BE
MEASURED?
Criticismofsystemsbiologyincludesthefollowing:“it’stooslow;
it’stooexpensive;it’saﬁshingexpedition.”Wereadilyadmitthat
systems approaches are currently driven more by technology and
computing than by a clear understanding of the data. Indeed, a
major challenge is to thoroughly mine the existing data before
accumulating even more information. However, critics must be
cognizantoftheimmensechallengesinvolvedwiththisapproach.
For example, we need to create a new interdisciplinary culture
along with a new vocabulary. We need to break down the tradi-
tional silos of information present in most scientiﬁc research en-
deavors.Weneedtomergetheexperimentalwiththeclinicalwith
FIG 2 Iterative cycles of perturbation biology. The infectious disease questions, the ﬁrst step in the cycle, determine the appropriate biological models and
technologies utilized to generate multidimensional data. Data analysis and integration identify key components, pathways, and networks which allow for the
construction of a predictive model. Model-predicted biological bottlenecks or key network nodes are validated by performing additional targeted experiments
anddataintegration,resultinginareﬁnedmodel.Importantly,severalroundsofbiologicalperturbations(i.e.,useofmutantpathogens,cellularsmallinterfering
RNA [siRNA] knockdowns or knockout mice) are required to produce a predictive model that could be effectively utilized by the general infectious disease
community. In addition to a more comprehensive understanding of the host-pathogen response and testable models, this type of perturbation biology will
produce publicly disseminated multidimensional data sets and potentially both diagnostic signatures and drug targets.
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betweendiversemembersofthescientiﬁccommunitywhoother-
wise do not communicate with each other. The iterative cycle of
experimental design, sample preparation, high-throughput as-
says, and data integration and analysis that is an absolute require-
ment for an effective systems approach is a lengthy, repetitious,
and unglamorous process. But without this iterative progression,
predictive and revealing models are not achievable.
We acknowledge that the best response to this criticism is to
provide fundamental knowledge directly relevant to human
health that could not otherwise be achieved through traditional
scientiﬁc approaches: better cures and vaccines and better drugs
anddiagnostics.Butjustassystemsbiologydiffersinmanyaspects
frommoretraditionalbasicresearchapproaches,themethodsfor
measuring success also differ. Although publications are one im-
portantmeasurement,anadditionalmeasureofsuccessistheuti-
lization of the generated resources by the scientiﬁc community,
including experimental data sets, software tools, computational
models,andresearchprotocols,allmadeavailabletothescientiﬁc
community through the four Centers’ and NIAID websites (http:
//www.niaid.nih.gov/labsandresources/resources/sb/Pages
/default.aspx). We call upon researchers outside the Centers to
utilize the vast data sets and other resources being generated to
furthertheknowledgeandunderstandingofpathogen-hostinter-
actions.
As highlighted in a recent review, systems biology is already
making important contributions to cancer research (7). The ap-
proach has been used to identify network motifs that can accu-
ratelypredictthedevelopmentofdistantmetastasesinbreastcan-
cer patients—tumors that may develop years after the primary
tumor and which frequently prove fatal. A network-centric ap-
proach has also identiﬁed speciﬁc oncogenes in certain types of
B-celllymphomas,andamultiscalemathematicalmodelhasbeen
developed to test the efﬁcacy of different radiation protocols,
whichhasledtoimprovementsinradiationtherapiesforcolorec-
tal cancer. The cancer ﬁeld was one of the ﬁrst research commu-
nities to aggressively embrace (and fund) the use of systems biol-
ogy. We believe that the infectious disease community will build
on the resulting substantial systems biology methodologies and
insights to claim similar successes in the near future. We invite
your thoughts and comments on this perspective.
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